Cumberland Pharmaceuticals
CPIX
47 hedge funds and large institutions have $30.2M invested in Cumberland Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
4% more funds holding
Funds holding: 45 → 47 (+2)
11% less capital invested
Capital invested by funds: $34.1M → $30.2M (-$3.92M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.35M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
+$593K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$209K |
| 4 |
CCM
Coldstream Capital Management
Bellevue,
Washington
|
+$129K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$68.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIM
Kestrel Investment Management
San Mateo,
California
|
-$1.07M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$384K |
| 3 |
Two Sigma Advisers
New York
|
-$198K |
| 4 |
Two Sigma Investments
New York
|
-$197K |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
-$187K |
CPIX Hedge Fund Activity: Q1 2014 in Review
47 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q1 2014, worth a combined $30.2M — down 11% from $34.1M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CPIX positions and 5 closed out — a net gain of 2 holders — while 15 added to existing stakes and 12 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $1.35M. The largest seller was Kestrel Investment Management, cutting an estimated $1.07M.
- 47 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q1 2014, up from 45 in Q4 2013.
- Funds reported $30.2M of Cumberland Pharmaceuticals stock for Q1 2014, down 11% quarter-over-quarter.
- 7 funds opened new Cumberland Pharmaceuticals positions in Q1 2014 and 5 closed out, a net change of +2 holders.
- The largest Cumberland Pharmaceuticals buyer in Q1 2014 was Millennium Management, an estimated $1.35M added.
- The largest Cumberland Pharmaceuticals seller in Q1 2014 was Kestrel Investment Management, an estimated $1.07M sold.
Based on aggregated 13F filings for Q1 2014.